Literature DB >> 18817927

Magnetic resonance imaging as a potential gold standard for infarct quantification.

Marcus Carlsson1, Hakan Arheden, Charles B Higgins, Maythem Saeed.   

Abstract

Accurate diagnosis, characterization, and quantification of myocardial infarction (MI) is essential to assess the impact of therapy and to aid in predicting prognosis of patients with ischemic heart disease. Delayed contrast-enhanced magnetic resonance (DE-MR) imaging has the potential of being the gold standard for quantification of MI. It has also been useful in correlating electrocardiography abnormalities with the location and transmurality of infarction. The focus of this review is to address the strengths and limitations of DE-MR imaging in the detection and quantification of MI for clinicians and investigators in the field of electrocardiology. The biological rationale and technical background for detecting MI by DE-MR imaging were reviewed as well as the different approaches for quantification of the DE-MR images, exemplified by patient cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817927     DOI: 10.1016/j.jelectrocard.2008.06.010

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  13 in total

1.  Head-to-head comparison of a 2-day myocardial perfusion gated SPECT protocol and cardiac magnetic resonance late gadolinium enhancement for the detection of myocardial infarction.

Authors:  Marcus Carlsson; Fredrik Hedeer; Henrik Engblom; Hakan Arheden
Journal:  J Nucl Cardiol       Date:  2013-07-10       Impact factor: 5.952

2.  Evaluation of myocardial viability in myocardial infarction patients by magnetic resonance perfusion and delayed enhancement imaging.

Authors:  W Sun; L Sun; F Yang; X Zhao; R Cai; W Yuan
Journal:  Herz       Date:  2018-10-15       Impact factor: 1.443

3.  Disappearance of myocardial perfusion defects on prone SPECT imaging: comparison with cardiac magnetic resonance imaging in patients without established coronary artery disease.

Authors:  Bo Hedén; Eva Persson; Marcus Carlsson; Olle Pahlm; Håkan Arheden
Journal:  BMC Med Imaging       Date:  2009-08-10       Impact factor: 1.930

4.  Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography.

Authors:  Peder Sörensson; Einar Heiberg; Nawsad Saleh; Frederic Bouvier; Kenneth Caidahl; Per Tornvall; Lars Rydén; John Pernow; Håkan Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2010-04-30       Impact factor: 5.364

Review 5.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

6.  Agreement of left ventricular mass in steady state free precession and delayed enhancement MR images: implications for quantification of fibrosis in congenital and ischemic heart disease.

Authors:  Sigurdur S Stephensen; Marcus Carlsson; Martin Ugander; Henrik Engblom; Goran Olivecrona; David Erlinge; Hakan Arheden
Journal:  BMC Med Imaging       Date:  2010-01-24       Impact factor: 1.930

7.  Optical projection tomography permits efficient assessment of infarct volume in the murine heart postmyocardial infarction.

Authors:  X Zhao; J Wu; C D Gray; K McGregor; A G Rossi; H Morrison; M A Jansen; G A Gray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

8.  Diagnostic accuracy of cardiac magnetic resonance tissue tracking technology for differentiating between acute and chronic myocardial infarction.

Authors:  Huaibi Huo; Xu Dai; Simiao Li; Yue Zheng; Jie Zhou; Yao Song; Shuang Liu; Yang Hou; Ting Liu
Journal:  Quant Imaging Med Surg       Date:  2021-07

9.  Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction.

Authors:  Peder Sörensson; Lars Rydén; Nawsad Saleh; Per Tornvall; Håkan Arheden; John Pernow
Journal:  BMC Cardiovasc Disord       Date:  2013-03-25       Impact factor: 2.298

10.  Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo.

Authors:  Robert Jablonowski; David Nordlund; Mikael Kanski; Joey Ubachs; Sasha Koul; Einar Heiberg; Henrik Engblom; David Erlinge; Håkan Arheden; Marcus Carlsson
Journal:  BMC Cardiovasc Disord       Date:  2013-12-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.